Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2018 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Effect of brimonidine tartrate on basophil activation in glaucoma patients.
Rosenfeld E, Barequet D, Rabina G, Langier S, Lazar M, Shemesh G, Kurtz S, Kivity S. Rosenfeld E, et al. Int J Ophthalmol. 2020 Mar 18;13(3):509-512. doi: 10.18240/ijo.2020.03.21. eCollection 2020. Int J Ophthalmol. 2020. PMID: 32309191 Free PMC article.
AIM: To evaluate the mechanism of which brimonidine tartrate 0.15% causes clinical hypersensitivity. METHODS: A prospective case-control study comparing 8 glaucoma patients with clinical hypersensitivity to brimonidine to a control group consist …
AIM: To evaluate the mechanism of which brimonidine tartrate 0.15% causes clinical hypersensitivity. METHODS: A prospec …
Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%-timolol 0.5% therapy.
Motolko MA. Motolko MA. Curr Med Res Opin. 2008 Sep;24(9):2663-7. doi: 10.1185/03007990802333167. Epub 2008 Aug 7. Curr Med Res Opin. 2008. PMID: 18691444 Clinical Trial.
CONCLUSIONS: The brimonidine-timolol fixed combination was associated with a 50% lower incidence in ocular allergy compared with 0.2% brimonidine monotherapy. ...Additional studies are needed to evaluate the incidence of ocular allergy associated with brim …
CONCLUSIONS: The brimonidine-timolol fixed combination was associated with a 50% lower incidence in ocular allergy compared wi …
Hypertensive acute granulomatous anterior uveitis as a side effect of topical brimonidine.
Clemente-Tomás R, Arciniegas-Perasso CA, Hervás-Hernandis JM, García-Ibor F, Ruiz-Del Río N, Duch-Samper AM. Clemente-Tomás R, et al. Arch Soc Esp Oftalmol (Engl Ed). 2018 Oct;93(10):511-514. doi: 10.1016/j.oftal.2018.05.005. Epub 2018 Jun 15. Arch Soc Esp Oftalmol (Engl Ed). 2018. PMID: 29910082 English, Spanish.
CLINICAL CASE: The case concerns an 81-year-old woman on treatment with a topical fixed combination of timolol and brimonidine who was diagnosed in the Emergency Department with acute anterior granulomatous hypertensive uveitis. The patient responded favourably to t …
CLINICAL CASE: The case concerns an 81-year-old woman on treatment with a topical fixed combination of timolol and brimonidine …